Back
Atara Biotherapeutics Stock Price Chart
The Fed Just Cut Rates-Here's Alex Green's $1 Million AI Stock Picks
Watch Alex Green's breakdown and discover the next big AI winners!
Sell
20
ATRA
Atara Biotherapeutics
Last Price:
8.03
Seasonality Move:
-9.83%
7 Day Trial
ALL ACCESS PASS
$
7
The Tech Disruption Wall Street Isn't Talking About...Yet
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- The current trend is relatively stagnant and ATRA is experiencing slight buying pressure.
Atara Biotherapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.71 | Buy |
| 20-day SMA: | 8.27 | Sell |
| 50-day SMA: | 8.33 | Sell |
| 200-day SMA: | 13.79 | Sell |
| 8-day EMA: | 7.84 | Buy |
| 20-day EMA: | 8.01 | Buy |
| 50-day EMA: | 8.62 | Sell |
| 200-day EMA: | 17.17 | Sell |
Atara Biotherapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.15 | Sell |
| Relative Strength Index (14 RSI): | 49.9 | Sell |
| Chaikin Money Flow: | 21080 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.13 - 8.91) | Buy |
| Bollinger Bands (100): | (7.24 - 13.32) | Sell |
Atara Biotherapeutics Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Atara Biotherapeutics Stock
Is Atara Biotherapeutics Stock a Buy?
- Atara Biotherapeutics share price is 8.08 while ATRA 8-day simple moving average is 7.71, which is a Buy signal.
- The stock price of ATRA is 8.08 while Atara Biotherapeutics 20-day SMA is 8.27, which makes it a Sell.
- Atara Biotherapeutics 50-day simple moving average is 8.33 while ATRA share price is 8.08, making it a Sell technically.
- ATRA stock price is 8.08 and Atara Biotherapeutics 200-day simple moving average is 13.79, creating a Sell signal.
ATRA Technical Analysis vs Fundamental Analysis
Sell
20
Atara Biotherapeutics (ATRA)
is a Sell
Is Atara Biotherapeutics a Buy or a Sell?
-
Atara Biotherapeutics stock is rated a Sell
The current Atara Biotherapeutics [ATRA] share price is $8.08. The Score for ATRA is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
Atara Biotherapeutics Stock Info
Market Cap:
45.82M
Price in USD:
8.08
Share Volume:
106.76K
Atara Biotherapeutics 52-Week Range
52-Week High:
45.75
52-Week Low:
4.97
Sell
20
Atara Biotherapeutics (ATRA)
is a Sell
Atara Biotherapeutics Share Price Forecast
-
What is the Atara Biotherapeutics stock price today?
The Atara Biotherapeutics stock price is 8.08 USD today. -
Will ATRA stock go up or go down?
Atara Biotherapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Atara Biotherapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Atara Biotherapeutics is overvalued.
Is Atara Biotherapeutics Stock a Buy?
- Atara Biotherapeutics share price is 8.08 while ATRA 8-day exponential moving average is 7.84, which is a Buy signal.
- The stock price of ATRA is 8.08 while Atara Biotherapeutics 20-day EMA is 8.01, which makes it a Buy.
- Atara Biotherapeutics 50-day exponential moving average is 8.62 while ATRA share price is 8.08, making it a Sell technically.
- ATRA stock price is 8.08 and Atara Biotherapeutics 200-day simple moving average is 17.17, creating a Sell signal.
Fundamental Analysis of Atara Biotherapeutics
Is Atara Biotherapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.28 per share, an increase next quarter of $8.28 per share, an increase this year of $42.84 per share, and a decrease next year of $64.80 per share.
Technical Analysis of Atara Biotherapeutics
Should I short Atara Biotherapeutics stock?
- ATRA Moving Average Covergence Divergence (MACD) indicator is -0.15, suggesting Atara Biotherapeutics is a Sell
- Atara Biotherapeutics Relative Strength Index (RSI) is 49.9, which suggest Atara Biotherapeutics is oversold
- The Bollinger Bands (25) for Atara Biotherapeutics is (7.13 - 8.91), which suggest Atara Biotherapeutics is a Sell
- The Bollinger Bands (100) for Atara Biotherapeutics is (7.24 - 13.32), which suggest Atara Biotherapeutics is a Sell
* Atara Biotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.